Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 3/20 | 0.91 |
| ▸ | HTR1A | P08908 | 1/20 | 0.36 |
| ▸ | HTR2C | P28335 | 1/20 | 0.36 |
| ▸ | DRD3 | P35462 | 1/20 | 0.36 |
| ▸ | TAOK3 | Q9H2K8 | 1/20 | 0.35 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2618855 | 1.00 | CTSS (0.91) | CTSSHTR1AHTR2CDRD3TAOK3 | |
| SCHEMBL2618613 | 0.95 | CTSS (1.00) | CTSSHTR1AHRH3MAPTNPC1 | |
| SCHEMBL2610222 | 0.90 | CTSS (0.85) | CTSSMAPTNPC1S1PR2 | |
| SCHEMBL2713563 | 0.87 | CTSS (0.86) | CTSSHTR1AMAPTS1PR2 | |
| SCHEMBL2618905 | 0.87 | CTSS (0.86) | CTSSHTR1AMAPTS1PR2 | |
| SCHEMBL2712451 | 0.87 | CTSS (0.86) | CTSSHTR1AMAPTS1PR2 | |
| SCHEMBL2618738 | 0.85 | CTSS (1.00) | CTSSMAPTS1PR2 | |
| SCHEMBL2710565 | 0.85 | CTSS (1.00) | CTSSMAPTS1PR2 | |
| SCHEMBL31285784 | 0.85 | CTSS (1.00) | CTSSMAPTS1PR2 | |
| SCHEMBL2726066 | 0.85 | CTSS (0.69) | CTSSHTR1AHTR2CDRD3TAOK3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2630141-A1 | CATHEPSIN S INHIBITOR COMPOUNDS | Eli Lilly and Company (US) | 2013-08-28 | — | — | EP | disclosed |
| WO-2012054315-A1 | CATHEPSIN S INHIBITOR COMPOUNDS | ELI LILLY AND COMPANY (US) | 2012-04-26 | — | — | WO | disclosed |